February 27, 2017 10:14 AM EST
R&D
Pharma

Gern­gross’ Adimab hands over RSV an­ti­bod­ies to Ar­sa­nis, a biotech he co-found­ed in Vi­en­na

Arsalan Arif

Founder

Till­man Gern­gross is tak­ing a group of an­ti­bod­ies iden­ti­fied by his dis­cov­ery group Adimab and hand­ing them over to Ar­sa­nis, a Vi­en­na-based biotech he …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ap­plied Ther­a­peu­tic­s' rare dis­ease drug gets a CRL

FDA is look­ing in­to hema­tol­ogy risks af­ter pa­tients take Blue­bird's Skysona gene ther­a­py

PTC re­ports Phase 2 ALS fail, sells pri­or­i­ty re­view vouch­er for $150M

Bris­tol My­ers sues the fed­er­al gov­ern­ment over 340B, fol­low­ing oth­er drug­mak­ers

Nor­bert Bischof­berg­er's time as Kro­nos CEO ends as biotech seeks new life

No­var­tis to cut 139 jobs in NJ as part of com­mer­cial re­fo­cus

A service from the Financial Times